more respiratory diseases Flashcards
Non-infectious respiratory diseases excluding malignancies, COPD, and asthma.
risk factors for pulmonary embolism
thrombosis
malignancy
surgery
immobility
definition of embolism
a mass of material in the vascular system lodged in a vessel blocking its lumen
most common cause of pulmonary embolism
DVT
signs of first class pulmonary embolism
idiopathic pulmonary hypertension
small level pulmonary deficiency
signs of second class pulmonary embolism
acute respiratory and cardiac problems
chest pain
shortness of breath
right heart strain
ECG signs of second class pulmonary embolism
deep S waves in lead I
presence of Q waves and inverted T waves in lead 3
sign of third class pulmonary embolism
sudden death
treatment of pulmonary embolism
anticoagulants (heparin and warfarin)
thrombolysis
risk factors for sarcoidosis
age 20-29
women >40
coeliac disease
Black people (increased genetic tendency)
pathology of sarcoidosis
non-caseating granulomas
signs of sarcoidosis
wheezing
coughing
chest pain
diagnostic tests for sarcoidosis
CT PET biopsy test tissues to rule out other causes bloods - increased ESR
treatment of sarcoidosis
anti-inflammatories
give corticosteroids if patient has parenchymal lung disease, uveitis, hypercalcaemia, or neurological or cardiac involvement
pathology of idiopathic pulmonary fibrosis
active lung epithelium produces mediators –> differentiation in myofibroblasts –> produce excess extracellular matrix –> remodelling of lung architecture and deposition of collagen
signs of idiopathic pulmonary fibrosis
dry cough malaise weight loss cyanosis finger clubbing
complications of idiopathic pulmonary fibrosis
respiratory failure
increased risk of lung cancer
diagnostic tests for idiopathic pulmonary fibrosis
ABG - decreased Pao2 and increased PaCO2
CXR/CT - decreased lung volume and honeycomb lung (essential for diagnosis)
spirometry - restrictive
biopsy
treatment for idiopathic pulmonary fibrosis
corticosteroids
antifibrinitic drugs (pirfenidone)
tyrosine kinase inhibitors (nintedanib)
transplant
how do tyrosine kinase inhibitors work against idiopathic pulmonary fibrosis?
reduce fibroblast proliferation
reduce production of collagen and fibrogenic mediators
inhibit other growth factor receptors
risk factors for pleural effusion
heart failure
TB
cirrhosis
pathology of pleural effusion
damage to pleura leads to secretion of fluid which is in greater volume than can be absorbed by the lymphatic system
signs of pleural effusion
bronchial breathing
decreased expansion
decreased percussion (stony dull)
decreased vocal resonance